Phenylethanoids, phenylpropanoids, and phenolic acids quantification vis-à-vis gene expression profiling in leaf and root derived callus lines of Rhodiola imbricata (Edgew.)

https://doi.org/10.1016/j.indcrop.2020.112708Get rights and content

Highlights

  • First ever study on high frequency callus induction from R. imbricata root explant.

  • UPLC-PDA based method developed and validated for metabolite quantification.

  • Established callus morpho-variants for metabolite enriched biomass accumulation.

  • RT-qPCR gene expression showed a positive correlation with metabolite content.

  • Year-round callus biomass production to obtained desired metabolites.

Abstract

Salidroside and rosavins have been found as the most potent ingredients used in Rhodiola based herbal formulations. Rhodiola imbricata is a medicinal herb of the trans-Himalayan Ladakh region of India. Since, the natural supply of this herb is rapidly decreasing, due to its over-exploitation, high altitude region, and traditional usage in the Amchi system of medicine. In the present study, friable callus culture was developed for the first time from leaf and root explants of R. imbricata. Furthermore, callus cell lines were also evaluated for rapid growth rate and high metabolite accumulation. The results revealed that callus induction frequency observed in juvenile leaves (100 %) and roots (87.50 %) in MS medium enriched with 0.5 mg/L TDZ and 1 mg/L NAA. Scanning electron microscopy (SEM) analysis was done for histological observations of the callus surface. A selective and efficient ultra-performance liquid chromatography with PDA detector (UPLC-PDA) method was developed and validated for the quantification of phenylethanoids, phenylpropanoids, and phenolic acids. The maximum salidroside was detected in leaf derived friable green calli (3.59 mg/g DW) subsequently followed by leaf derived friable white calli (2.31 mg/g DW). While rosavin and rosarin were detected maximum in root derived compact green calli (0.15 mg/g DW) and root derived friable green calli (0.07 mg/g DW). Genes encoding enzymes involved in salidroside and rosavins biosynthesis were also investigated for transcript abundance in wild as well as in vitro cultures using the RT-qPCR approach. The present study explained the friable callus culture as a potential alternative approach to obtain higher metabolite yield in R. imbricata. Further, it can be used for sequential scale-up of metabolite at bioreactor level to meet the industrial demand.

Introduction

Rhodiola imbricata (Crassulaceae) is a perennial medicinal herb; found at rocky slopes, wet places, and high altitude passes of Ladakh region, India (Chaurasia et al., 2003). It is well recognized for its valuable medicinal properties like radioprotection, immunomodulatory, antioxidant, anticancerous, freeze tolerance, anti-aging, wound healing, anti-fatigue and anti-stress due to the presence of diverse secondary metabolites, mainly phenylethanoids and phenylpropanoids (Chaurasia et al., 2003; Gupta et al., 2007; Kumar et al., 2011; Bhardwaj et al., 2018; Kapoor et al., 2018; Tao et al., 2018). Salidroside and rosavins are the most important bioactive component of Rhodiola sp. due to their potential applications used in pharmaceutical, nutraceutical, aerospace, sports sector, and health care industries (Furmanowa et al., 1995; Arora et al., 2005; Chawla et al., 2010; Gupta et al., 2007; Mishra et al., 2009; Panossian et al., 2010; Galambosi et al., 2010; Tayade et al., 2013; Tao et al., 2018). In recent decades interest of researchers on applications of Rhodiola has increased tremendously due to their industrial and market demand (approximately 20–30 tons raw material/year) (Kotiranta et al., 1998; Grech-Baran et al., 2015; Tao et al., 2018). At present, the worldwide market price for Rhodiola is about 6800 Rs/Kg of raw material and around thirty companies are listed as ingredient suppliers for different herbal formulation preparations such as Medi herbs- Rhodiola and ginseng complex (60 tablets-Rs. 2640) and The vitamin shoppe (500 mg Rhodiola Rs. 1631) (Ampong-Nyarko, 2005; Tao et al., 2018). Top key players i.e. Nature’s way; Chansha Organic Herb Inc; MB-holding GmbH & Co.; Amax Nutra Source; iHerb; Swanson health products; Xian Yuensun Biological Technology Co. Ltd; PLT Health Solutions, Inc; Xian Greena Biotech Co. Ltd. produced, promoted and marketed high-value Rhodiola enriched products and formulations (Anonymous, 2019).

Over the years, the rising demand of R. imbricata facilitated the over-exploitation vis-à-vis decreasing its natural population from wild, leads to put under a rare category in the red data list of Indian flora (Kumar et al., 2011). Conventional cultivation of R. imbricata has been challenged due to low seed viability, embryo abortion, and the inability of the plant to grow besides its natural habitat (Chaurasia et al., 2003; Kumar et al., 2011; Bhardwaj et al., 2018). Although, the average time to accumulate an ample level of active ingredients in naturally grown Rhodiola plants is 5–7 years (Galambosi, 2006). This is mainly due to slow growing nature, poor seed germination, and pollinator specificity due to the high altitude environment (Kumar et al., 2011; Galambosi, 2006). Therefore, considering the above fact there is a need to establish more effective alternative production strategies for its bioactive constituents (Chaurasia et al., 2003; Kumar et al., 2011; Bhardwaj et al., 2018).

Plant cell culture offers an economically feasible and recognized as a potential alternative sustainable platform for year-round production of desired metabolites (Kapoor et al., 2018; Eibl et al., 2018; Nordlund et al., 2018; Efferth, 2019; Kumar et al., 2020). Therefore, the present study investigated for the first time to develop a friable callus cell lines derived from leaf and root explants of R. imbricata for the production of commercially important metabolites. Furthermore, UPLC-PDA based analytical method was developed and validated using qualitative quantification of phenylethanoids, phenylpropanoids, and phenolic acid marker compounds i.e. gallic acid (1), salidroside (2), tyrosol (3), rosavin (4), rosarin (5), p-coumaric acid (6) and cinnamic acid (7). Also, to correlate and validate the metabolite content analysis, transcript level gene expression (RT-qPCR) profiling was investigated using key biosynthetic pathway genes of Rhodiola species.

Section snippets

Experimental material

R. imbricata plant material i.e. mature seeds and whole plants were collected from Changthang valley of Changla pass (Altitude; 5362 ± 6.7 m, 34°02.763″N & 77°55′.757″E) of Ladakh region, India (Fig. 1a & b). The sampling was done in July 2017 and collected experimental materials were kept inside the plant growth chamber with controlled temperature conditions (18 ± 2 °C), photoperiod (16/8 h light/dark), and relative humidity (60–65 %). Seeds were stored at 4 °C for further experimental work.

High frequency in vitro regeneration

For in vitro culture establishment; viable seeds were surface sterilized and germinated on half MS basal medium. High frequency seed germination (92.0 %) was observed on half MS basal media supplemented with 6 % sucrose concentration within three weeks of inoculation (Fig. 1d). Axenic culture developed from seeds were further transferred to full MS media enriched with different concentrations of plant growth regulators i.e. NAA, BAP, IAA, KIN and GA3 for efficient in vitro shoot and root

Conclusions

The in vitro cell culture system offers an economically viable and sustainable platform for the continuous homogenous production of bioactives in an eco-friendly manner. Like conventional means; seasonal and environmental factors are negligible and do not affect the continuous supply of raw material to pharmaceutical industries. Present studies explicitly demonstrated the screening of aged callus (55–60 days old) color morpho-variant for metabolite enriched cell line by optimizing culture

Author’s contribution

Shiv Rattan: Conceived the concept, Framed and conducted the experimental design, Data observation and statistical analysis, SEM study and analysis, Method development, validation and quantification of metabolites, Gene expression study and analysis and Manuscript written.

Archit Sood: Gene expression study and analysis and Manuscript written.

Pankaj Kumar: SEM study and analysis, Method development, validation and Manuscript written.

Anil Kumar: Method development, validation and quantification

Ethical approval

This article followed the ethical standard of the institute.

Declaration of Competing Interest

The authors declare that they have no conflict of interest.

Acknowledgments

The authors acknowledge the Council of Scientific and Industrial Research (CSIR), Government of India, under the project “Biotechnological interventions for sustainable bio-economy generation through characterization, conservation, prospection, and utilization of Himalayan bioresources (MLP-0201)” for providing financial support. SR acknowledges UGC, New Delhi for providing research fellowship and Academy of Scientific and Innovative Research (AcSIR), Government of India for Ph.D. enrolment.

References (56)

  • S. Wu et al.

    High yield production of salidroside in the suspension culture of Rhodiola sachalinensis

    J. Biotechnol.

    (2003)
  • H.S. Yu et al.

    Characterization of glycosyltransferases responsible for salidroside biosynthesis in Rhodiola sachalinensis

    Phytochemistry

    (2011)
  • P. Alam et al.

    HPTLC densitometric analysis of arbutin in bulk drug and methanolic extracts of Arctostaphylos uva-ursi

    Nat. Prod. Res.

    (2011)
  • F. Alperth et al.

    Qualitative and quantitative analysis of different Rhodiola rosea rhizome extracts by UHPLC-DAD-ESI-MSn

    Sci. Pharm.

    (2019)
  • K. Altantsetseg et al.

    Content of biologically active compounds in roseroot (Rhodiola sp.) raw material of different derivation

    Herba Pol.

    (2007)
  • K. Ampong-Nyarko

    Rhodiola rosea Potential Commercialization in Alberta. New Initiatives fund-2004/2005. Project 2004-2038, Final Report

    (2005)
  • Anonymous

    Rhodiola Root Market: Global Industry Size, Trends, Growth Analysis, Major Factors, Key Companies and Opportunities by 2026. Marketermedia.com/Rhodiola-root-market

    (2019)
  • R. Arora et al.

    Evaluation of radioprotective activities of Rhodiola imbricata Edgew.-a high altitude plant

    Mol. Cell. Biochem.

    (2005)
  • A.K. Bhardwaj et al.

    In vitro propagation, clonal fidelity and phytochemical analysis of Rhodiola imbricata Edgew: a rare trans-Himalayan medicinal plant

    Plant Cell Tiss. Organ Cult.

    (2018)
  • O.P. Chaurasia et al.

    Himalayan rose root, Rhodiola spp., potential health drink and drug plant

    Nat. Prod. Rad.

    (2003)
  • O.P. Chaurasia et al.

    Ethnobotany & Plants of Trans- Himalaya

    (2007)
  • R. Chawla et al.

    Himalayan Bioresource Rhodiola imbricata as a promising radioprotector for nuclear and radiological emergencies

    J. Pharm. Bioall. Sci.

    (2010)
  • K.I. Choe et al.

    The antioxidant and anti-inflammatory effects of phenolic compounds isolated from the root of Rhodiola sachalinensis A. BOR

    Molecules

    (2012)
  • J.L. Cui et al.

    Fungal endophyte-induced salidroside and tyrosol biosynthesis combined with signal cross-talk and the mechanism of enzyme gene expression in Rhodiola crenulata

    Sci. Rep.

    (2017)
  • A.G. Dubichev et al.

    Chemical composition of the rhizomes of the Rhodiola rosea by the HPLC method

    Chem. Nat. Compd.

    (1991)
  • R. Eibl et al.

    Plant cell culture technology in the cosmetics and food industries: current state and future trends

    App. Microbiol. Biotechnol.

    (2018)
  • M. Furmanowa et al.

    Rhodiola rosea L. (Roseroot): in vitro regeneration and the biological activity of roots. Biotechnology in agriculture and forestry

    (1995)
  • M. Furmanowa et al.

    Rhodiola rosea in vitro culture-phytochemical analysis and antioxidant action

    Acta Soc. Bot. Pol. Pol. Tow. Bot.

    (1998)
  • Cited by (0)

    View full text